Isolated Kidney Transplant in Primary Hyperoxaluria-1 Enabled by Small Interfering RNA (siRNA) Therapy. Is It Time for Change? Case Report and Review of the Literature.

Oxlumo (lumasiran) - Alnylam

Rivfloza (nedosiran) - Novo Nordisk

http://www.ncbi.nlm.nih.gov/pubmed/42080407

Eva Simkova; Haneen Yamin; Hazem S Awad; Loai A Eid; Martin Bitzan; Samhar Al-Akash; Shameer M Habeeb; Waldo Concepcion; Watfa S Aldhaheri

May 4, 2026